BG Medicine meets Nasdaq requirements, shares soar

BG Medicine (BGMD) jumps 15.2% after saying late yesterday that it has received confirmation that it is in compliance with the listing requirements of the Nasdaq Capital Market.

In November, when BG Medicine was traded on the Nasdaq Global Market, Nasdaq warned the firm that it was in breach of the exchange's requirements.

BG asked to transfer to the Capital Market, which has less strict rules; Nasdaq approved, but the company still had to meet the new requirements.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs